GHENT, Belgium – Patrik De Haes, CEO of Thrombogenics NV, rang the opening bell – albeit remotely – on the NYSE Euronext Brussels exchange to kick off proceedings at the 2013 Knowledge For Growth meeting at the International Convention Center in Ghent, Belgium, last Thursday.